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Raman spectroscopy uncovers 
biochemical tissue-related features 
of extracellular vesicles from 
mesenchymal stromal cells
Alice Gualerzi  1, Stefania Niada2,3, Chiara Giannasi2,3, Silvia Picciolini1,4, Carlo Morasso  1, 
Renzo Vanna1, Valeria Rossella5, Massimo Masserini4, Marzia Bedoni1, Fabio Ciceri6, Maria 
Ester Bernardo5, Anna Teresa Brini2,3 & Furio Gramatica1
Extracellular vesicles (EVs) from mesenchymal stromal cells (MSC) are emerging as valuable therapeutic 
agents for tissue regeneration and immunomodulation, but their clinical applications have so far been 
limited by the technical restraints of current isolation and characterisation procedures. This study 
shows for the first time the successful application of Raman spectroscopy as label-free, sensitive and 
reproducible means of carrying out the routine bulk characterisation of MSC-derived vesicles before 
their use in vitro or in vivo, thus promoting the translation of EV research to clinical practice. The Raman 
spectra of the EVs of bone marrow and adipose tissue-derived MSCs were compared with human 
dermal fibroblast EVs in order to demonstrate the ability of the method to distinguish the vesicles of 
the three cytotypes automatically with an accuracy of 93.7%. Our data attribute a Raman fingerprint 
to EVs from undifferentiated and differentiated cells of diverse tissue origin, and provide insights into 
the biochemical characteristics of EVs from different sources and into the differential contribution of 
sphingomyelin, gangliosides and phosphatidilcholine to the Raman spectra themselves.
Extracellular vesicles (EVs) are a heterogeneous group of membrane-bound vesicles that are constitutively 
released by cells of different tissue origins. Past controversies concerning nomenclature have now been resolved 
by the scientific community, which defines EVs as the group of particles made up of exosomes, microvesicles and 
apoptotic bodies1. Exosomes (30–100 nm) and microvesicles (up to 1000 nm) differ in size and cellular origin, but 
both mediate intercellular communication within a tissue and among organs thanks to body fluid transportation1.
As is the case for most body cells, part of the secretome of mesenchymal stromal cells (MSCs) includes 
exosomes and microvesicles, which are currently being investigated because of their striking regenerative and 
immunomodulating potential. The bioactive molecules loaded onto/into EVs are involved in the paracrine effects 
of stem cells, and even the membrane constituents of vesicles seem to trigger intracellular protective/regener-
ative pathways in recipient cells2. It has been suggested that MSC-derived EVs may be sometimes even more 
therapeutically valuable than whole cells, because of their remarkable handling advantages, which can accelerate 
their clinical application in the so-called cell therapy without cells3. The possibility of overcoming the cell therapy 
drawbacks of having to administer living, replicating and difficult to control cells is currently one of the main 
challenges facing regenerative medicine, and EVs can be an effective means of stimulating the restoration of 
organ function through tissue regeneration and repair in the context of an integrated strategy of regenerative 
rehabilitation4.
Over the last ten years, many studies have demonstrated the role that MSC-derived EVs can play in tissue 
repair and immunomodulation5, 6 and, in 2014, EVs ability to influence the activity of recipient cells and regulate 
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immune responses was successfully exploited in a patient undergoing allogeneic hematopoietic stem cell trans-
plantation who developed therapy-refractory graft-versus-host disease7. Their regenerative potential has also 
been assessed in in vitro and in vivo models of many diseases affecting heart8–10, kidney11–13, liver14, 15, bone and 
cartilage16, 17, muscle18, skin19, and central nervous system20–23.
However, there are still concerns about the effect that the source of MSCs and cell culture conditions can 
have on EV production and characteristics as there is no standardised and optimised method for isolating and 
characterising EVs. Furthermore, the technical restraints of current techniques have limited their potential use in 
regenerative medicine24, 25 by preventing reproducible quality and safety assessments26.
The aim of this study was to test Raman spectroscopy (RS) as a label-free, non-destructive, sensitive, rapid 
and automatable means of carrying out the bulk characterization of EVs. This technique provides a spectrum that 
qualitatively and quantitatively describes the chemical composition of a sample and thus avoids the need for spe-
cific protein biomarkers. It has been widely used in the pharmaceutical industry as a mean of verifying raw mate-
rials and quality controlling drug production, and we suggest it could help in purity and quality checking vesicle 
suspensions. It has already proved its value by characterising a wide range of cells and tissue samples for the 
purposes of basic research, and as an innovative alternative to classic, time-consuming and operator-dependent 
diagnostic methods27–34. In the field of regenerative medicine, it has been used to analyse undifferentiated and 
differentiated human and murine embryonic stem cells35–37 and to monitor MSCs stimulated towards osteogenic 
differentiation38, 39. Efforts have also been made to develop Raman-based methods for the individual characteri-
sation of human vesicles40, 41, but although these have provided information at single-vesicle level, they are still far 
from being used diagnostically. What is required to allow the immediate transferability of EV research to clinical 
practice is a procedure that allows i) the rapid characterisation of a sample before its use in vitro or in vivo; ii) 
the identification of fingerprints of the EV populations used for regenerative purposes in order to determine the 
best experimental settings and compare results from different cell sources; and iii) the routine application of the 
analysis. The third point should be favoured by the current availability of portable Raman spectrometers that can 
automatically scan and analyse complex samples, which could bring Raman analysis easily in the reach of most 
laboratories. RS is much more suitable for achieving these goals than the widely used techniques of immunob-
lotting, cytofluorimetry and spectrometry because it can provide reproducible results quickly and in a label-free 
manner, and only requires tiny sample volumes in comparison with the large amounts needed by other methods, 
which cannot easily cope with the nanoscalar dimensions of exosomes.
This study provides the first Raman-based characterisation of the EVs of human MSCs isolated from 
bone-marrow (bone marrow mesenchymal stromal cells, BM-MSCs) and subcutaneous adipose tissue (adipose 
tissue mesenchymal stromal cells, ASCs). The results were compared with those obtained using EVs released by 
dermal fibroblasts (DFs), in order to verify the ability of Raman analysis to distinguish vesicles from undiffer-
entiated and differentiated cells, and gain insights into the biochemical features of EVs from different sources. 
Multivariate analysis was used to assess spectral differences and automatically distinguish the three groups. In 
addition, given the growing body of evidence concerning the pivotal role of lipids in mediating EV functions42, 
we also evaluated the contribution of lipid membrane constituents to the Raman spectra. Our findings provide 
evidence supporting the use of RS for the routine characterisation of MSC-derived EVs before their in vitro/in 
vivo application.
Results
EV characterisation. EVs were isolated from BM-MSCs, ASCs and DFs following a multi-step ultracentrif-
ugation protocol43 and characterised by immunoblotting and transmission electron microscopy (TEM) to verify 
their peculiar features as suggested by the International Society for Extracellular Vesicles (ISEV)44.
Immunoblotting confirmed the presence of EVs carrying flotillin-1, CD63 and CD9, and a significant reduc-
tion in calnexin-positive vesicles (Fig. 1A). The TEM images (Fig. 1B–D) confirmed the typical morphology 
of the EVs, whose ultrastructure and size were consistent with published data45. The vesicles in all of the sam-
ples were round (Fig. 1B–D) and their general mean diameter as calculated on the TEM images was 46.5 nm 
(±15.8 nm) with slight differences among cell groups. Supplementary Figure S1 shows a box plot with all of the 
recorded measurements.
Raman spectroscopy biochemical overview of Evs. Freshly isolated EVs were analysed by RS in the 
spectral ranges of 500–1800 cm−1 and 2600–3200 cm−1, the most significant regions of the Raman spectrum for 
biological specimens. The spectra were obtained from random spots of air-dried drops of EV suspension and, 
given the size of the laser beam, we speculate that every spectrum described the biochemical features of small 
clusters of aggregated EVs.
Figure 2 shows representative mean Raman spectra (±1 standard deviation) of the vesicles isolated from the 
supernatants of BM-MSCs, ASCs and DFs. Each mean spectrum represents the average of 40–50 independent 
recordings obtained from all of the donors of the same cell type. The overall homogeneity in the spectra from the 
same tissue source underlines the reproducibility of the analytical method, which is not affected by the intrinsic 
inter-individual variability of donors.
The spectra showed characteristic Raman bands of nucleic acids (NAs, 720–820 cm−1), phenylalanine (Phe, 
1003 cm−1), lipid and protein markers such as CH and CH2 groups (bands respectively centred at 1450 cm−1 and 
2940 cm−1) (Fig. 2 and Table 1). In particular, lipids made a large contribution, which is in line with previously 
reported spectroscopic evidence40, 41, 46. Lipid content was characterised by peaks attributable to cholesterol and 
cholesterol ester (537; 702; 1130; 1442 cm−1) and peaks of varying intensity corresponding to the C-C stretch 
(around 1100 cm−1) and CH, CH2, and CH3 bonds (in the spectral range 2600–3200 cm−1). In addition, the areas 
usually assigned to NA bases (718; 748; 782 cm−1) and phosphate backbone (785; ~1060 cm−1) were variably 
prominent in the three average spectra. This is in line with many data demonstrating that EVs contain intact 
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mRNA, long non-coding RNA, miRNA and other forms of RNA loaded into EVs42. The recurrent peaks attribut-
able to proline/hydroxyproline (853; 920; 1206 cm−1) and tryptophan (752–760; 1208; 1360; 1555 cm−1) may be 
related to differences in cell metabolism and responses to serum-deprived culture conditions. Proline is known 
to be a signalling molecule and a sensor of cellular energy status when responding to metabolic stress47, and the 
kynurenine pathway of tryptophan has been reported as being involved in the immunosuppressive effects of 
MSCs48.
Comparison of the average spectra revealed many differences between the cytotypes (highlighted in bold 
characters in Table 1), suggesting discrepancies in the panel of protein biomarkers and lipid content of vesicles, 
although it is difficult to attribute divergences in peak intensity to specific molecules. The presence of a 1127 cm−1 
peak seemed to distinguish ASC spectra from those of both BM-MSC and DF EVs. The comparison of ASC and 
DF data highlighted minor divergences in the spectral range 2600–3200 cm−1, which is greatly influenced by lipid 
molecules thus indicating similarities in the lipid content of ASC- and DF-derived vesicles.
Lipid membrane constituents account for spectral differences. Principal Component Analysis 
(PCA) was used to simplify the original data (n = 198) and all of the spectra were collectively represented by 
their principal components (PCs). Starting from PC1 (which accounted for 37.1% of total variance), the subse-
quent PCs describe differences in the Raman fingerprint that were progressively less prominent (Supplementary 
Table S1 and Supplementary Fig. S2). The first 2 PCs (Fig. 3A) were used to build the scatter plot shown in Fig. 3B. 
Combined analysis of the scatter plot and the PC1 and PC2 spectra revealed that the positive loadings in the 
PC1 spectrum mainly describe the biochemical features of ASC-derived EVs, positive peaks in PC2 represent 
BM-MSC vesicles rather than ASC or DF vesicles. One-way ANOVA performed on PC1 and PC2 scores demon-
strated that the means of each group were significantly different (Prob > F < 0.05), despite within-group variance 
(Supplementary Table S2).
Based on the simple premise that a spectrum from a mixture of chemical ingredients is a mixture of the 
spectra from the pure ingredients, the PC1 and PC2 loadings were least squares fitted (classical least square 
(CLS) fitting) with specific reference spectra to investigate one possible cause of the observed spectral differences, 
Figure 1. EV characterisation by means of Western blotting and transmission electron microscopy.  
(A) Western blot analysis of extracellular vesicles-enriched fractions (EVs) produced by BM-MSC, ASCs 
and DFs using the indicated antibodies. Flotillin-1, CD63 and CD9 are positive markers for EVs and 
Calnexin is considered a negative one. Corresponding cell lysate (CL) was used as control and depicts 
the specificity of the three antibodies. Western blots were cropped to improve clarity. All bands within 
the range of the molecular markers were retained and processing of the film was applied equally across 
the entire image. (B–D) Representative transmission electron photomicrographs of ultracentrifuged EVs 
from BM-MSCs (B), ASCs (C) and DFs (D) conditioned medium. The TEM images were used for size 
measurements. Bars = 100 nm.
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following a previously reported procedure40. As we observed that the most variable spectral intervals in PC1 
and PC2 were related to lipids, the membrane components cholesterol (Chol), ceramide (Cer), sphingomyelin 
(SM), phosphatidylcholine (PCh), phosphatidylethanolamine (PE), phosphatidic acid (PA), and monosialotetra-
hexosylganglioside (GM1, reference molecule for monosialoganglioside family) were used for CLS fitting. Lipid 
reference molecules were preferred to protein markers because proteins spectra are dominated by backbone con-
formation signals, whereas lipids have more specific and defined peaks and can be more easily distinguished 
by RS. The resulting CLS fitting scores reported in Table 2 described the relative contribution of each standard 
molecule to PC1 and PC2 loadings, thus their contribution to the observed spectral differences between the three 
cytotypes. Figure 3C depicts the fitting coefficients in a bar graph, making apparent that SM and ganglioside 
(GM1) contribute to the shape of PC1 and PC2 loadings more than the other reference molecules. Similarly, PCh 
is the phospholipid which contributed most to fit the shape of PC1. In particular, the positive score attributed 
to SM after PC1 fitting demonstrated that it made a contribution to the spectrum of ASC-derived EVs, and this 
was further underlined by the negative SM score after PC2 fitting. On the contrary, GM1 and PCh were assigned 
a negative CLS fitting score in the case of PC1, suggesting their presence within the membrane of EVs from 
BM-MSCs and DFs rather than ASC-derived vesicles. After CLS fitting, the scores assigned to Chol, Cer, PE, and 
PA suggest their presence in the EVs from all three source cells, although they do not greatly contribute to the 
differences between EVs. It has to be noted that the considered lipids are only few of the constituents of vesicles, 
Figure 2. Raman fingerprint of BM-MSCs, ASCs, and DFs. Average Raman spectra obtained using an 
excitation wavelength of 532 nm and 10 seconds of exposure for 2 accumulations for each spectrum. The 
solid black line indicates the average of 40–50 spectra ± 1 standard deviation (shaded grey areas). The Raman 
bands corresponding to lipids are highlighted in yellow (500–540 cm−1; the band centred at 700 cm−1; 
1700–1740 cm−1; 2850–2950 cm−1), those corresponding to proteins are in blue (1200–1300 cm−1; the band 
centred at 1450 cm−1), and those corresponding to nucleic acids are in red (720–820 cm−1; the band centred 
at 915 cm−1; 1060–1100 cm−1; the band centred at 1360 cm−1). The arrows indicate the 1003 cm−1 peak of 
Phenylalanine.
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for this reason our results should be considered as hints for future studies aimed at verifying the exact membrane 
composition of vesicles.
Raman spectroscopy can distinguish BM-MSC, ASC and DF EVs with 93.7% accuracy. The 
first 25 PCs were used for Linear Discriminant Analysis (LDA), which made possible to verify the ability of 
the method to identify between-group differences by maximising the variance among classes while minimising 
intra-class variability. The results showed that RS clearly distinguished the biochemical fingerprints of the three 
groups. After leave-one-out cross-validation, the PCA-LDA model showed that the overall accuracy of the model 
was 93.7% and that its accuracy in distinguishing DFs from MSCs was 92% (Table 3). The LDA scatter plot (Fig. 4) 
revealed that the spectra of the ASC-derived EVs fell into a region that was clearly separated from those of the 
BM-MSC EVs. Although there was a limited overlap between the DF and ASC derived vesicles, RS distinguished 
their sources with a high degree of statistical confidence (Wilks’ Lambda Test, p < 0.001). Details concerning the 
distribution of the individual donor spectra are shown in Supplementary Figure S3.
Discussion
The possibility of using regenerative medicine to treat diseased, damaged or aged tissues and restore organ func-
tion without side effects is one of the main challenges facing modern medical science, and so is no surprise that 
the discovery of the regenerative potential of EVs released by MSCs has aroused great interest. However, the main 
obstacle to the clinical use of vesicles is the lack of a robust and standardised method of characterising them5.
In this study, we investigated the biochemical fingerprints of MSC-derived vesicles originating from different 
tissues and compared them with those of terminally differentiated dermal fibroblasts. Our findings demonstrate 
the ability of RS to identify tissue-related fingerprints for vesicles released by MSCs and fibroblasts without the 
Position (cm−1) Component
520 Phosphatidyinositol
524 Phosphatidylserine
537 Cholesterol ester
540 Glucose-saccharide band
596 Phosphatidylinositol
701–703 Cholesterol ester
720–820 Nucleic acids
752–760 Tryptophan
840–860 Polysaccharide structure
941 Polysaccharide structure
995 C-O band of ribose
1003 Phenylalanine
1048 Glycogen
1054 C-O and C-N stretching of proteins
1060–1095
C-C vibrations of lipids and carbohydrates
PO2− stretching of nucleic acids
1120 C-O band of ribose; carotenoids
1127 C-N stretching of proteins; ceramides
1200–1300
Amide III
1230–1240 for β-sheets; 1260–1300 for α-helix
1298 Fatty acids
1336 CH3CH2 wagging mode of polynucleotide chain (purine bases)
1337 Tryptophan; Glycine backbone and Proline side chain
1357; 1361 Guanine
1360 Tryptophan
1420–1480 CH functional groups of nucleic acids, proteins and lipids
1520–38 Carotenoids
1555–1558 Tryptophan
1716–1740 C=O group
2853–2881 CH2 symmetric and asymmetric stretches of lipids
2910 CH3 stretching vibrations
2940 CH and CH2 in lipids and proteins
Table 1. Main Raman peak assignments from literature refs 65–67. The major divergent peaks are highlighted 
in bold characters.
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use of any label. This is the first time that Raman analysis has been used to provide a biochemical overview of 
MSC-derived EVs from a limited volume of EV suspensions.
As previously reported in relation to other types of vesicles40, 41, 49, our data on MSC-derived EVs confirm the 
ability of RS to reveal the presence of the main EV constituents in a single repeatable spectrum. Although we 
cannot exclude the possible presence of a limited amount of soluble factors other than vesicles in our suspension, 
the reproducibility of the results and the main peak attributions suggest the purity of the samples.
Figure 3. Multivariate analysis of the Raman spectra. (A) Raman spectra of reference lipid molecules, PC1 
and PC2 that were considered for CLS fitting. The grey lines highlight the correspondences between the peaks 
of the standard lipids and the PC loadings. (B) Scatter plot of the PCA results showing the PC1 and PC2 scores 
assigned to each spectrum recorded from the EVs of BM-MSCs (pink), ASCs (blue) and DFs (green). Each 
square represents one spectrum. The scatter plot shows that a positive PC1 score described ASC-derived EVs 
better than those derived from DFs and BM-MSCs, whereas a positive PC2 score better described EVs derived 
from BM-MSC. (C) CLS scores obtained after fitting the spectra of Cer (light green), Chol (green), SM (light 
blue), GM1 (blue), PCh (pink), PE (red) and PA (violet) with the PC1 and PC2 loadings. The positive and 
negative scores obtained after CLS fitting are visualized as a bar graph and respectively indicate the contribution 
of each standard molecules to the positive or negative peaks visible in the PC1 and PC2 loadings. Cer: ceramide; 
Chol: cholesterol; SM: sphingomyelin; GM1: monosialotetrahexosylganglioside; PCh: phosphatidylcholine; PE: 
phosphatidylethanolamine; PA: phosphatidic acid.
% variance
CLS fitting scores
% ErrorChol Cer SM GM1 PCh PE PA
PC1 35.1 0.13 −0.19 0.76 −1.01 −0.99 −0.31 0.6 2.12
PC2 22.7 0.6 0.55 −0.15 −1.98 0.34 0.33 0.14 1.82
Table 2. Classical least-square (CLS) fitting. CLS fitting scores obtained after fitting the reference spectra 
of cholesterol (Chol), ceramide (Cer), sphingomyelin (SM), monosialotetrahexosylganglioside (GM1), 
phosphatidylcholine (PCh), phosphatidylethanolamine (PE), and phosphatidic acid (PA) to PC1 and PC2 
loadings. The reported fitting scores are a measure of the contribution of each molecule to the considered PC 
loadings and provide hints to explain spectral differences between EV spectra. The percentage of total variance 
of PC 1 and PC2 and the percentage of error obtained after CLS fitting are also reported.
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The main finding of this study is that RS can clearly distinguish not only vesicles from MSCs and terminally 
differentiated fibroblasts, but also vesicles of MSCs from bone marrow and adipose tissue. Although there are 
protein markers that define a stem cell phenotype exist, a straightforward distinction between bone-marrow and 
adipose-tissue MSCs, based on biological and functional features, is still difficult to be obtained50. The ability of 
RS to highlight unique, tissue-specific features of vesicles should therefore assist scientists working with stem 
cells. Even if assessing the possible correlation between biochemistry and function goes beyond the scope of this 
study, the biochemical variations observed provide suggestions for further investigations into the functional dif-
ferences of EVs from multiple MSC types and sources for which there is still not a definite marker51, 52.
Analysis of the spectra of MSC- and DF-derived EVs revealed that lipids made a substantial contribution to 
the Raman signals, as previously reported40, 41, 49. The prominence of membrane constituents in determining the 
fingerprints of vesicles is in line with the growing body of evidence demonstrating that lipids play a crucial role in 
the formation of EVs1 and the fulfilment of their signalling functions42. It is known that a number of specific lipids 
are typically associated with lipid rafts and enriched in vesicles that inherit the plasma membrane composition 
of their cell of origin. In particular, cholesterol and sphingolipids are preferentially included in EV membranes 
and may be involved in the formation of vesicles and in their stability in the extracellular environment42. There 
is also evidence that lipids are involved in BM-MSC responses to a strongly pro-inflammatory environment53. 
Furthermore, it is possible that direct membrane interactions between vesicles and recipient cells is one of the 
mechanisms of action of EVs, as has already been demonstrated in the case of whole cells2.
On the basis of CLS fitting results, we hypothesised that gangliosides, phosphatidylcholine and sphingomyelin 
directly contributed to the main spectral differences between the considered EVs. Our data are in agreement with 
those of a recent proteomic and lipidomic study demonstrating how sphingomyelins, ceramides, cholesterol and 
phosphatidylcoline were enriched in the exosomes of BM-MSCs in comparison with other cell types54, but there 
is still a lack of data concerning the membrane composition of ASC-derived exosomes. Our observation that 
GM1 also contributes to the recorded spectra of BM-MSC vesicles is in line with the reported functional role of 
gangliosides in regulating the proliferation and neuronal differentiation of MSCs55, 56. Similarly, it is known that 
ceramides and ceramide-containing lipids are involved in many of the pathways mediating immune responses, 
and that they modulate the adipogenic differentiation of MSCs57. Despite the reported functional significance of 
PA in the biogenesis and release of exosomes, our data did not reveal any significant difference of PA content in 
the EVs derived from the three cell types, as has also been noticed by Haraszti et al.54 Further lipidomic studies 
Predicted group
Total true Sensitivity Specificity AccuracyBM-MSC ASC DF
True group
BM-MSC 46 2 2 50 92% 98.7% 97.1%
ASC 1 97 7 105 92.4% 91.8% 92.1%
DF 1 7 35 43 81.4% 94.8% 92.1%
198 88.6% 95.1% 93.7%
Table 3. PCA-LDA confusion matrix. Confusion matrix obtained from the results of the multivariate LDA of 
the first 25 PCA scores after leave-one-out crossvalidation. True positives, true negatives, false positives, and 
false negatives were used to calculate the sensitivity, specificity and accuracy of the method.
Figure 4. Linear discriminant analysis. The first 25 PC loadings calculated by means of PCA were used for the 
LDA. The scatter plot shows the LDA scores obtained for EVs from BM-MSCs (pink), ASCs (blue), and DFs 
(green). Each square represents a single spectrum. The crosses indicate the mean canonical observation score 
obtained for each group.
www.nature.com/scientificreports/
8SCIeNtIFIC REPoRTS | 7: 9820  | DOI:10.1038/s41598-017-10448-1
are needed to verify the exact membrane composition of MSC-derived vesicles and to establish the role of lipid 
species in mediating vesicle function.
It is important to mention one limitation of our study related to the sex mismatch of our MSC donors. It is 
known that MSC activity and recipient responses are influenced by the sex of both donor and recipient because 
of circulating hormones58, but, to the best of our knowledge, no specific study has been published concern-
ing sex-related variations in the function of EVs derived from cultured cells. Studies evaluating the efficacy of 
MSC-derived EVs in vitro and in vivo rarely refer to the sex of the donors, but this is very useful and should be 
always clearly indicated together with donor age59. Future in-depth analyses of larger donor cohorts should eval-
uate age and sex-related differences in EV function and chemical composition.
In conclusion, our findings demonstrate that RS can determine the chemical content of EVs in a label- and 
sample processing- free manner. The proposed method can be immediately transferred into laboratory practice 
as it allows the bulk characterisation of vesicle suspensions before their use in vitro or in vivo. As independent 
MSC-derived EV preparations can have different therapeutic potentials, the overall characterisation of vesicles 
offered by Raman spectroscopy might become a pivotal quality check for comparing data coming from different 
experiments or research labs, and thus hasten the clinical application of stem cell-derived products.
Methods
All of the relevant experimental data have been submitted to the EV-TRACK knowledgebase (EV-TRACK ID: 
EV170012)60.
Cell cultures. Human BM-MSCs were isolated from the residual bone marrow cells of healthy bone marrow 
(BM) transplantation donors (3 male donors, age range: 17–20 y/o) after approval by the Institutional Review 
Board of San Raffaele Hospital. Human ASCs and DFs were isolated from waste materials of abdominoplasty and 
liposuction procedures performed at IRCCS Galeazzi Orthopaedic Institute (subcutaneous adipose tissue of 4 
female healthy donors - age range: 35–58 y/o - and de-epidermised dermis of 3 female healthy donors – age range: 
26–46 y/o-, respectively). Tissues were collected following the procedure PQ 7.5.125 regarding waste materials 
to be used for research purposes, version 4 dated 22.01.2015, approved by the same institute. Written informed 
consent was obtained from all of the patients in accordance with the ethical principles of the Declaration of 
Helsinki. All of the samples were anonymised and no information or images that could lead to identification of 
a study participant might occur. All experiments were performed in accordance with the relevant guidelines and 
regulations of San Raffaele Hospital and IRCCS Galeazzi Orthopaedic Institute.
Cells were isolated following previously described protocols61–63. Briefly, mononuclear cells from BM aspirates 
were isolated by means of density gradient centrifugation (Ficoll 1.077 g/ml; Lympholyte, Cedarlane Laboratories 
Ltd., Burlington, Canada) and plated in non-coated 75–150 cm2 tissue culture flasks (BD Falcon, Franklin Lakes, 
NJ, USA) at a density of 160,000/cm2 in complete culture medium: DMEM (Euroclone, Milan, Italy) supple-
mented with 10% ultracentrifuged foetal bovine serum (Gibco, Life Technologies LTD, Paisley, UK), penicillin 
50 U/ml, 50 µg/ml streptomycin and 2 mM L-glutamine (L-Glu, Euroclone). Cultures were maintained at 37 °C in 
a humidified atmosphere, containing 5% CO2. After 48-hour culture, non-adherent cells were removed. The ASCs 
were isolated from adipose tissue samples following digestion with 0.75 mg/ml type I Collagenase (250 U/mg, 
Worthington Biochemical Corporation, Lakewood, NJ, USA) and the filtering of the stromal vascular fraction. 
The DFs were obtained from de-epidermised dermis fragmented and digested with 0.1% collagenase type I. The 
ASCs and DFs (plating density: 105 cells/cm2) were cultured (37 °C, 5% CO2) in complete culture medium. The 
medium was replaced every other day and, at 70–80% confluence, the cells were detached with 0.5% trypsin/0.2% 
EDTA, plated (BM-MSC plating density 4,000 cells/cm2; ASC plating density 10,000 cells/cm2; DF plating den-
sity 5,000 cells/cm2) and expanded. Once at 80–90% confluence, cells at 3rd–4th passage were washed twice with 
DMEM, kept for one hour in serum-free DMEM (phenol-free DMEM supplemented with 2 mM L-glutamine, 
50U/ml penicillin, 50 µg/ml streptomycin) and then cultured for 72 hours in serum-free DMEM.
Extracellular vesicle isolation. In order to avoid the presence of RS-visible isolation reagent residues in 
the EV suspension, the vesicles were isolated from cell-conditioned medium (CM) by means of differential cen-
trifugation, as previously described43. Briefly, after 72 hours of starvation, the medium conditioned from approx-
imately 6 × 106 cells was centrifuged at 800 g for 10 min to remove non-adherent cells and then at 2,500 g for 
15 min to remove potential apoptotic bodies. CM was then ultracentrifuged for 70 min at 100,000 g (L7–65; Rotor 
55.2 Ti; Beckman Coulter, Brea, CA, USA) at 4 °C, and the pellet was re-suspended in sterile saline solution 
and ultracentrifuged again. The collected EV suspension (approximately 500 µl) was kept at 4 °C before making 
Raman and TEM analyses, and then frozen.
Western blotting. Immunoblotting was performed to characterise the EVs as suggested by ISEV minimal 
experimental requirements44. The EV pellets were re-suspended in SDS sample buffer with protease inhibitors64. 
Electrophoresis was performed under reducing conditions, and then proteins were transferred to nitrocellulose 
membrane. The antigens were probed with anti-flotillin-1 (BD Transduction Laboratories™, San Jose, CA, USA), 
anti-CD63 and anti-CD9 (System Biosciences, Palo Alto, CA, USA), and anti-calnexin (endoplasmic reticulum 
protein used as negative control, clone C5C9, Cell Signaling Technology, Danvers, MA, USA). As secondary anti-
bodies goat anti-mouse (Thermo Fisher Scientific, Waltham, MA, USA) and goat anti-rabbit (System Biosciences) 
conjugated with HRP were used. Cell lysates were considered as the control for the specificity and working con-
ditions of the considered antibodies.
Transmission electron microscopy and size measurement. For the TEM visualisation of EVs, 5 µl of 
purified exosomes were absorbed on Formvar carbon-coated grids for 10 min. The drops were then blotted with 
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filter paper and negatively stained with 2% uranyl acetate (5 μl) in aqueous suspension for 10 min. Excess of uranyl 
was removed by touching the grid to a filter paper. The grids were dried at room temperature and examined with a 
transmission electron microscope (Leo 812AB, Zeiss, Oberkochen, Germany) at 80 kV. The TEM images obtained 
in order to verify EV ultrastructure were used to assess vesicles’ size using the particle analysis tool of ImageJ 
software (National Institutes of Health, Bethesda, MD, USA). At least 30 measurements per sample were done.
Raman spectroscopy. Freshly isolated EVs were analysed by means of Raman microspectroscopy (LabRAM 
Aramis, Horiba Jobin Yvon S.A.S, Lille, France) equipped with a diode-pumped solid-state laser operating at 
532 nm and a Peltier-cooled CCD detector. 5–10 µl drops of EV suspension were deposited on a calcium fluoride 
slide and allowed to air dry. All of the measurements were performed with 50× objective (NA 0.75, Olympus, 
Tokyo, Japan), 1800 grooves/mm diffraction grating, 400 µm entrance slit, and confocal mode (600 µm pinhole) in 
the spectral ranges 500–1800 cm−1 and 2600–3200 cm−1. Accumulation times were 2 × 10 s per spectrum.
The Raman shift was calibrated automatically using LabSpec 6 software (Horiba) using zero order line and Si 
line of a Si reference sample. In order to capture the spectra randomly, maps of about 150 µm2 (with lateral steps 
of 20–30 µm) were acquired in the centre and at the borders of the air-dried drops. Before analysing the data, a 
two-class hierarchical clustering analysis (HCA) of the Raman maps was made in order to distinguish the spectra 
relating to vesicles from those related to background. At least 10 independent replicates of the Raman spectra 
were obtained for every donor of the different cell types.
Data analysis. Baseline correction was made using LabSpec 6 processing tool by fitting all spectra with a 
sixth order polynomial curve in order to remove autofluorescence and background before unit vector normali-
sation. Post-acquisition calibration was carried out on normalised spectra, in order to compensate for possible 
thermal drifts.
Principal component analysis (PCA) of the normalised and aligned spectra was made in order to reduce the 
dimension of the data and describe their major trends. The provided principal components (PCs) represent dif-
ferences in the spectra of vesicles from the three cytotypes and therefore in their chemical composition. The first 
25 PC scores were used in a supervised classification model, linear discriminant analysis (LDA), in order to dis-
criminate and classify the data by maximizing the variance between groups. Data reduction by PCA before LDA 
was essential because LDA requires that the number of variables is smaller than the number of observations. The 
smallest number of PC scores was selected for the LDA to prevent data overfitting. A decreased number of PCs 
reduced the accuracy of the method in distinguishing the EVs, whereas an increased number did not improve the 
classification, but progressively decreased accuracy. Leave-one-out cross-validation was used to test the classifi-
cation sensitivity, specificity, and accuracy of the LDA model. One-way ANOVA was performed on PC scores to 
verify that the means of each group were significantly different, despite within-group variance.
Data manipulations and statistical analysis were performed using Origin2017 (v. 9.4, OriginLab, 
Northampton, MA, USA).
CLS fitting. Reference molecules of some of the major known constituents of EV membrane were used to 
investigate the lipid content of vesicles. Cholesterol (Chol), ceramide (N-stearoyl-D-erythro-sphingosine; Cer), 
sphingomyelin (SM), phosphatidylcholine (16:0/22:6; PCh), L-α-phosphatidylethanolamine (PE), phosphatidic 
acid (PA), and monosialotetrahexosylganglioside (GM1) were purchased from Avanti Polar Lipids (Alabaster, AL, 
USA) and used to acquire reference spectra using the same acquisition settings as those used for the EV analysis.
Labspec 6 was used for the Classical Least-Squares (CLS) fitting of the PC1 and PC2 spectra, which allows to 
calculate the contribution of the reference chemicals to the PC spectra by evaluating any similarities. The resulting 
coefficients described the relationships between the PC spectra and the reference molecules.
Data availability. The datasets generated and analysed during the current study are available from the cor-
responding author on reasonable request.
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